Results 251 to 260 of about 2,035,272 (261)

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine, 2015
Bernard Zinman, Christoph Wanner, John M Lachin   +2 more
exaly  

Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance

New England Journal of Medicine, 2001
Jaana Lindstr̈Om, Johan G Eriksson, T T Valle   +2 more
exaly  

Diabetes Care at Diabetes Camps

Diabetes Care, 2004
Francine, Kaufman, Desmond, Schatz, Janet, Silverstein   +2 more
openaire   +2 more sources

Effects of Intensive Glucose Lowering in Type 2 Diabetes

New England Journal of Medicine, 2008
Hertzel C Gerstein, Michael E Miller, Robert P Byington   +2 more
exaly  

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

New England Journal of Medicine, 2016
Steven P Marso, Agostino Consoli, Esteban Jódar   +2 more
exaly  

Leptin revisited: its mechanism of action and potential for treating diabetes

Nature Reviews Drug Discovery, 2012
Roberto Coppari, Christian Bjørbæk
exaly  

ANDROGEN DEPRIVATION RAISES RISK OF DIABETES, HEART DISEASE

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2019
Vlado Perković, Meg J Jardine, Bruce Neal   +2 more
exaly  

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2019
Itamar Raz, Marc P Bonaca, Ofri Mosenzon   +2 more
exaly  

Diabetes Care at Diabetes Camps

Diabetes Care, 2005
openaire   +2 more sources